Zurcher Kantonalbank (Zurich Cantonalbank) Arvinas, Inc. Transaction History
Zurcher Kantonalbank (Zurich Cantonalbank)
- $39 Billion
- Q2 2025
A detailed history of Zurcher Kantonalbank (Zurich Cantonalbank) transactions in Arvinas, Inc. stock. As of the latest transaction made, Zurcher Kantonalbank (Zurich Cantonalbank) holds 9,634 shares of ARVN stock, worth $93,931. This represents 0.0% of its overall portfolio holdings.
Number of Shares
9,634
Previous 9,634
-0.0%
Holding current value
$93,931
Previous $67,000
4.48%
% of portfolio
0.0%
Previous 0.0%
Shares
16 transactions
Others Institutions Holding ARVN
# of Institutions
245Shares Held
68.3MCall Options Held
2.99MPut Options Held
534K-
Vanguard Group Inc Valley Forge, PA9.39MShares$91.6 Million0.0% of portfolio
-
Black Rock Inc. New York, NY6.26MShares$61 Million0.0% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il3.67MShares$35.8 Million0.0% of portfolio
-
Logos Global Management LP San Francisco, CA3.3MShares$32.2 Million3.14% of portfolio
-
D. E. Shaw & Co., Inc. New York, NY2.15MShares$21 Million0.01% of portfolio
About ARVINAS, INC.
- Ticker ARVN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 53,205,300
- Market Cap $519M
- Description
- Arvinas, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of therapies to degrade disease-causing proteins. Its lead product candidates include Bavdegalutamide, a proteolysis targeting chimera (PROTAC) protein degrader that is in phase I clinical trial targeting the androgen receptor ...